Venrock

two arrows pointing different directions
Biotech

Candid scores Nasdaq listing via reverse merger Rallybio

The deal will allow Candid to trade on the Nasdaq while dumping RallyBio’s own rare disease maternal-fetal medicine assets.
Will Maddox Mar 2, 2026 11:45am
Hundred dollar bills flowing out of faucet

Angitia raises $130M to advance bone-building bispecifics

Feb 5, 2026 10:17am
Graphic images of different entities adding money to a pile

Tubulis touts $361M series C as next-gen ADC data drop nears

Oct 15, 2025 5:01am
Pencil filling out Scantron test form

AIRNA preps for clinical test with $155M series B

Apr 1, 2025 7:00am
money flying in

ADC biotech adds on $135M series B

Nov 25, 2024 7:00am
mountain top climb

Paragon spinout Apogee makes debut with $169M

Dec 7, 2022 6:30am